Platelet aggregation and exogenous factors from animal sources

Current Drug Targets - Cardiovascular and Haematological Disorders

Volumn 4, Issue 4, 2004, Pages 301-325

  Manjunatha Kini, R ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Antiplatelet drugs; C type lectins; Disintegrins; Fibrinogenase; Phospholipase A2; Platelet agglutination; Platelet aggregation inducers; Platelet aggregation inhibitors; Platelet glycoproteins; Platelet receptors; Thrombin like enzymes

Indexed keywords

AGKICETIN; ANTITHROMBOCYTIC AGENT; ARGININE; ASPARTIC ACID; BOTHROJARACIN; DECORSIN; DISAGREGIN; DISINTEGRIN; ECHICETIN; EPTIFIBATIDE; FIBRINOGEN; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCINE; LECTIN; MAMBIN; ORNATIN A2; ORNATIN A3; ORNATIN B; ORNATIN C; ORNATIN D; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; SAVIGNYGRIN; SERINE PROTEINASE; SNAKE VENOM; TRIPEPTIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VARIABILIN; VITRONECTIN RECEPTOR;

ANTIANGIOGENIC ACTIVITY; ANTIGEN ANTIBODY REACTION; CANCER INHIBITION; CARDIOVASCULAR DISEASE; DRUG RECEPTOR BINDING; DRUG RESEARCH; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; HEMATOLOGIC DISEASE; HUMAN; MELANOMA; MOLECULAR MECHANICS; MOLECULAR WEIGHT; NONHUMAN; OSTEOPOROSIS; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN STRUCTURE; REVIEW; SALIVARY GLAND; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION;

ANIMALS; BIOLOGICAL FACTORS; DISINTEGRINS; ELAPID VENOMS; HEMAGGLUTINATION; HUMANS; LECTINS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; SALIVARY GLANDS; VIPER VENOMS;

EID: 9544254847     PISSN: 15680061     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568006043335835     Document Type: Review

References (315)

1. Zucker, M. B. Platelet aggregation measured by the photometric method. Meth. Enzymol., 1989, 169, 117-133.
2. Vargaftig, B. B., Chignard, M., Benveniste, J. Present concepts on the mechanisms of platelet aggregation. Biochem. Pharmacol., 1981, 30, 263-271.
3. George, J. N., Nurden, A. T., Phillips, D. R. Platelet Membrane Glycoproteins. Plenum Press: New York, 1985.
4. Peerschke, E. I. B. The platelet fibrinogen receptor. Semin. Hematol., 1985, 22, 241-259.
5. Westwick, J., Scully, M. F., Macintyre, D. E., Kalckar, V. V. Advances in Experimental Medicine and Biology, Vol. 192, Mechanisms of Stimulus-Response Coupling in Platelets. Plenum Press: New York, 1985.
6. Holmsen, H. Platelet Responses and Metabolism. Vol. I-III, CRC Press: Boca Raton, FL, 1986.
7. Colman, R. W. Platelet activation: role of an ADP receptor. Semin. Hematol., 1986, 23, 119-128.
8. Leung, L. and Nachman, R. Molecular mechanisms of platelet aggregation. Ann. Rev. Med., 1986, 37, 179-186.
9. Moroose, R., Hoyer, L. W. Von Willebrand factor and platelet function. Ann. Rev. Med., 1986, 37, 157-163.
10. Phillips, D. R., Shuman, M. A. Biochemistry of Platelets Academic Press: Orlando, FL, 1986.
11. Packham, M. A., Mustard, J. F. In Platelet Responses and Metabolism. Responses; Holmsen, H., Ed.; CRC Press: Boca Raton, FL, 1986; Vol. I, pp. 267-283.
12. Niewiarowski, S. Platelet membrane components and receptors. Hematologia, 1987, 20, 3-14.
13. Derenleau, D. A. Blood platelet shape change ABCs. Trends Biochem. Sci., 1987, 12, 439-442.
14. Jamieson, G. A. Progress in Clinical and Biological Research, Vol. 283, Platelet Membrane Receptors: Molecular Biology, Immunology, Biochemistry, and Pathology. Alan R. Liss: New York, 1988.
15. Kunicki, T. J. Platelet membrane glycoproteins and their function: an overview. Blut, 1989, 59, 30-34.
16. Kroll, M., Schafer, A. I. Review article. Biochemical mechanisms of platelet activation. Blood, 1989, 74, 1181-1195.
17. Shuman, M. A., Greenberg, C. S. In Biochemistry of Platelets; Phillips, D. R., Shuman, M. A., Eds.; Academic Press: Orlando, FL, 1986; pp. 319-346.
18. Tracy, P. B., Mann, K. G. In Platelet Responses and Metabolism; Holmsen, H., Ed.; CRC Press: Boca Raton, FL, 1986; Vol. I, Responses, pp. 297-324.
19. Tracy, P. B., Mann, K. G. 1986b In Biochemistry of Platelets; Phillips, D. R., Shuman, M. A., Eds.; Academic Press: Orlando, FL, 1986; pp. 295-318.
20. Ganz, P. R., Tackaberry, E. S., Rock, G. In Progress in Clinical and Biological Research; Jamieson, G. A., Ed.; Alan R. Liss: New York, 1988; Vol. 283, Platelet Membrane Receptors: Molecular Biology, Immunology, Biochemistry, and Pathology, pp. 255-261.
21. Stormorken, H. In Platelet Responses and Metabolism. Responses; Holmsen, H., Ed.; CRC Press: Boca Raton, FL, 1986; Vol. 1, pp. 3-32.
22. Packham, M. A., Mustard, J. F. The role of platelets in the development and complications of atherosclerosis. Semin. Hematol., 1986, 23, 8-26.
23. Hara, Y., Steiner, M., Baldini, M. G. Characterization of the platelet- aggregating activity of tumor cells. Cancer Res. 1980 40, 1217-1222.
24. Grignani, G., Pacchiarini, L., Almasio, P., Pagliarino, M., Gamba, G., Rizzo, S. C., Ascari, E. Characterization of the platelet-aggregating activity of cancer cells with different metastatic potential. Eur. J. Cancer, 1986, 38, 237-244.
25. Lerner, W. A., Pearlstein, E., Ambrogio, C., Karpatkin, S. A new mechanism for tumor-induced platelet aggregation. Comparison with mechanisms shared by other tumors with possible pharmacologic strategy toward prevention of metastases. Eur. J. Cancer, 1983, 31 463-469.
26. Pacchiarini, L., Grignani, G., Pagliarino, M., Ricetti, M.M., Bottazzi, B., Montovani, A., Ascari, E. Role of tumor proteinases in tumor cell-induced platelet aggregation. Invasion Metastasis, 1986, 6, 287-301.
27. Esumi, N., Todo, S., Imashuku, S. Platelet aggregating activity mediated by thrombin generation in the NCG human neuroblastoma cell line. Cancer Res., 1987, 47, 2129-2135.
28. Bastida, E., Almirall, L., Ordinas, A. Tumor-cell-induced platelet aggregation is a glycoprotein-dependent and lipooxygenase-associated process. Int. J. Cancer, 1987, 39 760-763.
29. Sakai, T., Lund-Hansen, T., Paborsky, L., Pedersen, A. H., Kisiel, W. Binding of human factors VII and VIIa to a human bladder carcinoma cell line (J82). Implications for the initiation of the extrinsic pathway of blood coagulation. J. Biol. Chem., 1989, 264, 9980-9988.
30. Hilgard, P., Thornes, R. D. Anticoagulants in the treatment of cancer. Eur. J. Cancer, 1976, 12, 755-762.
31. Karpatkin, S., Pearlstein, E. Role of platelets in tumor cell metastases. Ann. Inter. Med., 1981, 95, 636-641.
32. Gastpar, H. Platelet aggregation inhibitors and cancer. Ann. Chir. Gynaec., 1982, 71, 142-150.
33. Rickles, F. R., Edwards, R. L. Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood, 1983, 62, 14-31.
34. Plow, E. F., Marguerie, G., Ginsberg, M. H, Fibrinogen, fibrinogen receptors, and the peptides that inhibit these interactions. Biochem. Pharmac., 1987, 36, 4035-4040.
35. Frazier, W, A. Thrombospondin: a modular adhesive glycoprotein of platelets and nucleated cells. J. Cell Biol., 1987, 105, 625-632.
36. Plow, E. F., Loftus, J. C., Levin, E. G., Fair, D. S., Dixon, D., Forsyth, J., Ginsberg, M. H. Immunologic relationship between platelet membrane glycoprotein GP IIb/IIIa and cell surface molecules expressed by a variety of cells. Proc. Natl. Acad. Sci. U. S. A., 1986, 83, 6002-6006.
37. Charo, I. F., Fitzgerald, L. A., Steiner, B., Rall, Jr. S. C., Bekeart, L. S., Phillips, D. R. Platelet glycoproteins IIb and IIIa: evidence for a family of immunologically and structurally related glycoproteins in mammalian cells. Proc. Natl. Acad. Sci. U S. A., 1986, 83, 8351-8355.
38. Teng, C. M., Ko, F. N., Yu, S. M. Inventory of exogenous factors affecting platelet aggregation isolated from plant sources. Thromb. Haemost., 1994, 71, 517-519.
39. Teng, C. M., Ko, F. N. Antiplatelet agents isolated from medicinal plants. Res. Commun. Mol. Pathol. Pharmacol., 1998, 102, 211-225.
40. Smith, S. C., Brinkhous, K. M. Inventory of exogenous platelet-aggregating agents derived from venoms. Thromb. Haemost., 1991, 66, 259-263.
41. Pirkle, H. Thrombin-like enzymes from snake venoms: an updated inventory. Thromb. Haemost., 1998, 79, 675-683.
42. Teng, C. M., Ko, F. N. Comparison of the platelet aggregation induced by three thrombin-like enzymes of snake venoms and thrombin. Thromb. Haemost., 1988, 59, 304-309.
43. Nishida, S., Fujimura, Y., Miura, S., Ozaki, Y., Usami, Y., Suzuki, M., Titani, K., Yoshida, E., Sugimoto, M., Yoshioka, A., Fukui, H. Purification and characterization of bothrombin, a fibrinogen-clotting serine protease from the venom of Bothrops jararaca. Biochemistry, 1994, 33, 1843-1849.
44. Farid, T. M., Tu, A. T., El Asmar, M. F. Effect of cerastobin, a thrombin-like enzyme from Cerastes vipera (Egyptian sand snake) venom, on human platelets. Haemostasis, 1990, 20, 296-304.
45. Marrakchi, N., Zingali, R. B., Karoui, H., Bon, C., El Ayeb, M. Cerastocytin, a new thrombin-like platelet activator from the venom of the Tunisian viper Cerastes cerastes. Biochim. Biophys. Acta, 1995, 1244, 147-156.
46. Marrakchi, N., Barbouche, R., Guermazi, S., Karoui, H., Bon, C., El Ayeb, M. Cerastotin, a serine protease from Cerastes cerastes venom, with platelet-aggregating and agglutinating properties. Eur. J. Biochem., 1997, 247, 121-128.
47. Basheer, A. R., El Asmar, M. F., Soslau, G. Characterization of a potent platelet aggregation inducer from Cerastes cerastes (Egyptian sand viper) venom. Biochim. Biophys. Acta, 1995, 1250, 97-109.
48. Djebari, L. F., Martin Eauclaire, M. F., Mauco, G., Marchot, P. Afaâcytin, an αβ-fibrinogenase from Cerastes cerastes (horned viper) venom, activates purified factor X and induces serotonin release from human blood platelets. Eur. J. Biochem., 1995, 233, 756-765.
49. Serrano, S, M., Matos, M. F., Mandelbaum, F. R., Sampaio, C. A. Basic proteinases from Bothrops moojeni (Caissaca) venom - I. Isolation and activity of two serine proteinases, MSP 1 and MSP 2, on synthetic substrates and on platelet aggregation. Toxicon, 1993 31, 471-481.
50. Serrano, S. M., Mentele, R., Sampaio, C. A., Fink, E. Purification, characterization, and amino acid sequence of a serine proteinase, PA-BJ, with platelet-aggregating activity from the venom of Bothrops jararaca. Biochemistry, 1995, 34, 7186-7193.
51. Ouyang, C., Teng, C. M. The action mechanism of the purified platelet aggregation principle of Trimeresurus mucrosquamatus venom. Thromb. Haemost., 1979, 41, 475-490.
52. 2 that induces platelet aggregation. Toxicon, 1988, 26, 199-206.
53. 2 from snake and bee venoms on rabbit platelet function. Toxicon, 1984, 22, 705-718.
54. Teng, C. M., Chen, Y. H., Ouyang, C. Biphasic effect on platelet aggregation by phospholipase a purified from Vipera russelli snake venom. Biochim. Biophys. Acta, 1984, 772, 393-402.
55. Teng, C. M., Chen, Y. H., Ouyang, C. H. Effect of Russell's viper venom phospholipase A on blood coagulation and platelet aggregation. Semin. Thromb. Hemost., 1985, 11, 367-372.
56. 2 on platelet aggregation in comparison with those produced by arachidonic acid and lysophosphatidylcholine. Thromb. Res., 1986, 44, 875-886.
57. 2 from the venom of Agkistrodon acutus (five pace snake) and its effect on platelet aggregation. Toxicon, 1989, 27, 675-682.
58. Landucci, E. C., Condino-Neto, A., Perez, A. C., Hyslop, S., Corrado, A. P., Novello, J. C., Marangoni, S., Oliveira, B., Antunes, E., de Nucci, G. Crotoxin induces aggregation of human washed platelets. Toxicon, 1994, 32, 217-226.
59. 2. Biochim. Biophys. Acta 1994, 1214, 88-96.
60. Gartner, T. K., Stocker, K., Williams, D. C. Thrombolectin: a lectin isolated from Bothrops atrox venom. FEBS Lett., 1980, 117, 13-16.
61. 2+-dependent β-galactoside-specific lectins from snake venoms. Biochem. J., 1984, 224, 301-307.
62. Ogilvie, M. L., Dockter, M. E., Wenz, L., Gartner, T. K. Isolation and characterization of lactose-binding lectins from the venoms of the snakes Lachesis muta and Dendroaspis jamesonii. J. Biochem. (Tokyo), 1986, 100, 1425-1431.
63. Ogilvie, M. L., Byl, J. W., Gartner, T. K. Platelet-aggregation is stimulated by lactose-inhibitable snake venom lectins. Thromb. Haemost., 1989, 62, 704-707.
64. Vargaftig, B. B., Prado-Franceschi, J., Chignard, M., Lefort, J., Marlas, G. Activation of guinea-pig platelets induced by convulxin, a substance extracted from the venom of Crotalus durissus cascavella. Eur. J. Pharmacol., 1980, 68, 451-464.
65. Vargaftig, B. B., Joseph, D., Wal, F., Marlas, G., Chignard, M., Chevance, L. G. Convulxin-induced activation of intact and of thrombin-degranulated rabbit platelets: specific crossed desensitisation with collagen. Eur. J. Pharmacol., 1983, 92, 57-68.
66. Prado-Franceschi, J., Tavares, D. Q., Hertel, R., Lobo de Araujo, A. Effects of convulxin, a toxin from rattlesnake venom, on platelets and leukocytes of anesthetized rabbits. Toxicon, 1981 19, 661-666.
67. Marlas, G. Purification and preliminary structure of a potent platelet aggregating glycoprotein isolated from the venom of Crotalus durissus cascavella. Toxicon, 1982, 20, 289-290.
68. Marlas, G., Joseph, D., Huet, C. I. Isolation and electron microscope studies of a potent platelet-aggregating glycoprotein from the venom of Crotalus durissus cascavella. Biochimie, 1983, 65 405-416.
69. Marlas, G., Joseph, D., Huet, C. Subunit structure of a potent platelet-activating glycoprotein isolated from the venom of Crotalus durissus cascavella. Biochimie, 1983, 65, 619-628.
70. Faili, A., Randon, J., Francischetti, I. M., Vargaftig, B. B., Hatmi, M. Convulxin-induced platelet aggregation is accompanied by a powerful activation of the phospholipase C pathway. Biochem. J., 1994, 298, 87-91.
71. Francischetti, I. M., Saliou, B., Leduc, M., Carlini, C. R., Hatmi, M., Randon, J., Faili, A., Bon, C. Convulxin, a potent platelet-aggregating protein from Crotalus durissus terrificus venom, specifically binds to platelets. Toxicon, 1997, 35 1217-1228.
72. 1. J. Biol. Chem., 1997, 272, 27035-27041.
73. Ouyang, C., Yeh, H. I., Huang, T. F. Purification and characterization of a platelet aggregation inducer from Calloselasma rhodostoma (Malayan pit viper) snake venom. Toxicon, 1986, 24, 633-643.
74. Huang, T. F., Liu, C. Z., Yang, S. H. Aggretin, a novel platelet-aggregation inducer from snake (Calloselasma rhodostoma) venom, activates phospholipase C by acting as a glycoprotein Ia/IIa agonist. Biochem. J., 1995, 309, 1021-1027.
75. Shin, Y., Morita, T. Rhodocytin, a functional novel platelet agonist belonging to the heterodimeric C-type lectin family, induces platelet aggregation independently of glycoprotein Ib. Biochem. Biophys. Res. Commun., 1998, 245, 741-745.
76. Inoue, K., Ozaki, Y., Satoh, K., Wu, Y., Yatomi, Y., Shin, Y., Morita, T. Signal transduction pathways mediated by glycoprotein Ia/IIa in human platelets: comparison with those of glycoprotein VI. Biochem. Biophys. Res. Commun., 1999, 256, 114-120.
77. Ouyang, C., Wang, J. P., Teng, C. M. A potent platelet aggregation inducer purified from Trimeresurus mucrosquamatus snake venom. Biochim. Biophys. Acta, 1980, 630, 246-253.
78. Teng, C. M., Liao, K. K., Wang, J. P., Lin, H. S., Ouyang, C. Ultrastructure changes and release reaction of platelets induced by an aggregation inducer purified from Trimeresurus mucrosquamatus (Formosan habu) snake venom. Toxicon, 1981, 19, 121-130.
79. Teng, C. M., Ko, F. N., Tsai, I. H., Hung, M. L., Huang, T. F. Trimucytin: A collagen-like aggregating inducer isolated from Trimeresurus mucrosquamatus snake venom. Thromb. Haemost., 1993, 69, 286-292.
80. Chen, J. H., Wan, H., Ruan, C. Activation of human platelets induced by the aggregoserpentin of Trimeresurus mucrosquamatus venom (TMVA). In Hemostasis and Animal Venoms; Pirkle, H., Markland, F. S, Jr., Eds.; Marcel Dekker: New York, 1988; pp. 411-421.
81. Ouyang, C., Huang, T. F. A potent platelet aggregation inducer from Trimeresurus gramineus snake venom. Biochim. Biophys. Acta, 1983, 761, 126-134.
82. Teng, C. M., Hung, M. L., Huang, T. F., Ouyang, C. Triwaglerin: a potent platelet aggregation inducer purified from Trimeresurus wagleri snake venom. Biochim. Biophys. Acta, 1989, 992, 258-264.
83. Teng, C. M., Lee, L. G., Lee, C. Y., Ferlan, I. Platelet aggregation induced by equinatoxin. Thromb. Res., 1988, 52 401-411.
84. Sakurai, Y., Fujimura, Y., Kokubo, T., Imamura, K., Kawasaki, T., Handa, M., Suzuki, M., Matsui, T., Titani, K., Yoshioka, A. The cDNA cloning and molecular characterization of a snake venom platelet glycoprotein lb-binding protein, mamushigin, from Agkistrodon halys blomhoffii venom. Thromb. Haemost., 1998, 79, 1199-1207.
85. Peng, M., Lu, W., Kirby, E. P. Alboaggregin-B: a new platelet agonist that binds to platelet membrane glycoprotein Ib. Biochemistry 1991, 30, 11529-11536.
86. Peng, M., Lu, W., Kirby, E. P. Characterization of three alboaggregins purified from Trimeresurus albolabris venom. Thromb. Haemost., 1992, 67, 702-707.
87. Kowalska, M. A., Tan, L., Holt, J. C., Peng, M., Karczewski, J., Calvete, J. J., Niewiarowski, S. Alboaggregins A and B. Structure and interaction with human platelets. Thromb. Haemost., 1998, 79, 609-613.
88. Peng, M., Lu, W., Beviglia, L., Niewiarowski, S., Kirby, E. P. Echicetin: a snake venom protein that inhibits binding of von Willebrand factor and alboaggregins to platelet glycoprotein Ib. Blood 1993, 81, 2321-2328.
89. Chen, Y. L., Tsai, J. H. Functional and sequence characterization of agkicetin, a new glycoprotein Ib antagonist isolated from cAgkistrodon acutus venom. Biochem. Biophys. Res. Commun. 1995, 210, 472-477.
90. Taniuchi, Y., Kawasaki, T., Fujimura, Y., Suzuki, M., Titani, K., Sakai, Y., Kaku, S., Hisamichi, N., Satoh, N., Takenaka, T., Handa, M., Sawai, Y. Flavocetin-A and -B, two high molecular mass glycoprotein Ib binding proteins with high affinity purified from Trimeresurus flavoviridis venom, inhibit platelet aggregation at high shear stress. Biochim. Biophys. Acta, 1995, 1244, 331-338.
91. Kawasaki, T., Taniuchi, Y., Hisamichi, N., Fujimura, Y., Suzuki, M., Titani, K., Sakai, Y., Kaku, S., Satoh, N., Takenaka, T., Handa, M., Sawai, Y. Tokaracetin, a new platelet antagonist that binds to platelet glycoprotein Ib and inhibits von Willebrand factor-dependent shear-induced platelet aggregation. Biochem. J., 1995, 308 947-953.
92. Fujimura, Y., Ikeda, Y., Miura, S., Yoshida, E., Shima, H., Nishida, S., Suzuki, M., Titani, K., Taniuchi, Y., Kawasaki, T. Isolation and characterization of jararaca GPIb-BP, a snake venom antagonist specific to platelet glycoprotein Ib. Thromb. Haemost., 1995, 74, 743-750.
93. Read, M. S., Shermer, R. W., Brinkhous, K. M. Venom coagglutinin: an activator of platelet aggregation dependent on von Willebrand factor. Proc. Natl. Acad. Sci. U. S. A., 1978, 75, 4514-4518.
94. Read, M. S., Potter, J. Y., Brinkhous, K. M. Venom coagglutinin for detection of von Willebrand factor activity in animal plasmas. J. Lab. Clin. Med., 1983, 101, 74-82.
95. Read, M. S., Smith, S. V., Lamb, M. A., Brinkhous, K. M. Role of botrocetin in platelet agglutination: formation of an activated complex of botrocetin and von Willebrand factor. Blood, 1989, 74, 1031-1035.
96. Brinkhous, K. M., Barnes, D. S., Potter, J. Y., Read, M. S. Von Willebrand syndrome induced by a Bothrops venom factor: bioassay for venom coagglutinin. Proc. Natl. Acad Sci. U S. A., 1981, 78, 3230-3234.
97. Brinkhous, K. M., Read, M. S., Fricke, W. A., Wagner, R. H. Botrocetin (venom coagglutinin): reaction with a broad spectrum of multimeric forms of factor VIII macromolecular complex. Proc. Natl. Acad. Sci. U. S. A., 1983, 80, 1463-1466.
98. Howard, M. A., Perkin, J., Salem, H. H., Firkin, B. G. The agglutination of human platelets by botrocetin: evidence that botrocetin and ristocetin act at different sites on the factor VIII molecule and platelet membrane. Br. J. Haematol., 1984, 57, 25-35.
99. Takahashi, H., Nagayama, R., Hattori, A., Shibata, A. Botrocetin- and polybrene-induced platelet aggregation in platelet-type von Willebrand disease. Am. J. Hematol., 1985, 18, 179-189.
100. Fujimura, Y., Holland, L. Z., Ruggeri, Z. M., Zimmerman, T. S. The von willebrand factor domain-mediating botrocetin-induced binding to glycoprotein IB lies between Val449 and Lys728. Blood, 1987 70, 985-988.
101. Andrews, R. K., Booth, W. J., Gorman, J. J., Castaldi, P. A., Berndt, M. C. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex. Biochemistry, 1989, 28, 8317-8326.
102. Hamako, J., Matsui, T., Suzuki, M., Ito, M., Makita, K., Fujimura, Y., Ozeki, Y., Titani, K. Purification and characterization of bitiscetin, a novel von Willebrand factor modulator protein from Bitis arietans snake venom. Biochem. Biophys. Res. Commun., 1996 226, 273-279.
103. Ouyang, C. H., Ma, Y. H., Jih, H. C., Teng, C. M. Characterization of the platelet aggregation inducer and inhibitor from Echis carinatus snake venom. Biochim. Biophys. Acta, 1985 841, 1-7.
104. Teng, C. M., Ma, Y. H., Ouyang, C. H. Action mechanism of the platelet aggregation inducer and inhibitor from Echis carinatus snake venom. Biochim. Biophys. Acta, 1985, 841, 8-14.
105. Marshall, L. R., Herrmann, R. P. Plasma cofactors necessary for Enhydrina schistosa (beaked sea snake) venom to induce platelet aggregation. Thromb. Res., 1986, 43, 229-235.
106. Rees, R. S., Gates, C., Timmons, S., Des Prez, R. M., King, L. E., Jr. Plasma components are required for platelet activation by the toxin of Loxosceles reclusa. Toxicon, 1988, 26, 1035-1045.
107. Davey, M. G., Esnouf, M. P. The isolation of a component of the venom of Trimeresurus okinavensis that causes the aggregation of blood platelets. Biochem. J., 1969, 111, 733-743.
108. Li. J. Z., Lian, E. C. Mechanism of rabbit platelet agglutination induced by acidic mucopolysaccharide extracted from Stichopus japonicus Selenka. Thromb. Haemost., 1988, 59 432-434.
109. Li. J. Z., Lian, E. C. Aggregation of human platelets by acidic mucopolysaccharide extracted from Stichopus japonicus Selenka. Thromb. Haemost., 1988b, 59, 435-439.
110. Kini, R.M., Evans, H.J. Review article: Effects of snake venom proteins on blood platelets. Toxicon, 1990, 28, 1387-1422.
111. Ouyang, C., Teng, C. M., Huang, T. F. Characterization of snake venom components acting on blood coagulation and platelet function. Toxicon, 1992, 30, 945-966.
112. Niewiarowski, S., McLane, M. A., Kloczewiak, M., Stewart, G. J. Disintegrins and other naturally occurring antagonists of platelet fibrinogen receptors. Semin. Hematol., 1994, 31, 289-300.
113. Braud, S., Bon, C., Wisner, A. Snake venom proteins acting on hemostasis. Biochimie, 2000, 82, 851-859.
114. Teng, CM, Huang, TF. Inventory of exogenous inhibitors of platelet aggregation. Thrombos. Haemostas., 1991, 65, 624-626.
115. Kini, R.M., Chow, G. Exogenous inhibitors of platelet aggregation from animal sources. Thrombos. Haemostas., 2001, 85, 179-181.
116. Phillips, D. R., Charo, I. F., Parise, L. V., Fitzgerald, L. A. The platelet membrane glycoprotein IIb-IIIa complex. Blood, 1988, 71, 831-843.
117. Wagner, C. L., Mascelli, M. A., Neblock, D. S., Weisman, H. F., Coller, B. S., Jordan, R. E. Analysis of GPIIb/GPIIIa receptor number by quantification of 7E3 binding to human platelets. Blood, 1996 88, 907-914.
118. Jennings, L. K., Phillips, D. R. Purification of glycoproteins IIb and III from human platelet plasma membranes and characterization of a calcium-dependent glycoprotein IIb-III complex. J. Biol. Chem., 1982, 257, 10458-10466.
119. Fujimura, K., Phillips, D. R. Calcium cation regulation of glycoprotein IIb-IIIa complex formation in platelet plasma membranes. J. Biol. Chem., 1983, 258, 10247-10252.
120. Fitzgerald, L. A., Phillips, D. R. Calcium regulation of the platelet membrane glycoprotein IIb-IIIa complex. J. Biol. Chem., 1985, 260, 11366-11374.
121. Johnston, G. I., Heptinstall, S. Identity of saturable calcium-binding sites on blood platelets and their involvement in platelet aggregation. Thrombos. Haemos., 1988, 58, 54-61.
122. Rivas, G. A., Gonzalez-Rodriguez, J. Calcium binding to human platelet integrin GPIIb/IIIa and to its constituent glycoproteins. Effects of lipids and temperature. Biochem. J., 1991, 276 35-40.
123. Lefkovits, J., Plow, E. F., Topol, E. J. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N. Engl. J. Med., 1995, 332, 1553-1559.
124. Yamada, T., Matsushima, M., Inaka, K. Ohkubo, T., Uyeda, A., Maeda, T., Titani, K., Sekiguchi, K., Kikuchi, M. Structural and functional analyses of the Arg-Gly-Asp sequence introduced into human lysozyme. J. Biol. Chem., 1993, 268, 10588-10592.
125. 2 to human platelets: introduction of an RGD sequence by genetic engineering. Thrombos. Haemost., 1995, 74, 1138-1144.
126. Yang, Z. H., Jing, J., Tang, J. G. Inhibition of platelet aggregation of a mutant proinsulin molecule engineered by introduction of a native Arg-Gly-Asp sequence. Appl. Biochem. Biotechnol., 2001 90, 1-10.
127. Farrell, D. H., Thiagarajan, P., Chung, D. W., Davie, E. W. Role of fibrinogen α and γ chain sites in platelet aggregation. Proc. Natl. Acad. Sci. U. S. A., 1992, 89, 10729-10732.
128. Farrell, D. H., Thiagarajan, P. Binding of recombinant fibrinogen mutants to platelets. J. Biol, Chem., 1994, 269 226-231.
129. 3. EMBO J. 1996, 15, 5760-5771.
130. Gan, Z. R., Gould, R. J., Jacobs, J. W., Friedman, P. A., Polokoff, M. A. Echistatin. A potent platelet aggregation inhibitor from the venom of the viper, Echis carinatus. J. Biol. Chem., 1988 263, 19827-19832.
131. Huang, T. F., Holt, J. C., Kirby, E. P., Niewiarowski, S. Trigramin: primary structure and its inhibition of von Willebrand factor binding to glycoprotein IIb/IIIa complex on human platelets. Biochemistry, 1989, 28, 661-666.
132. Musial, J., Niewiarowski, S., Rucinski, B., Stewart, G. J., Cook, J. J., Williams, J. A., Edmunds, L. H., Jr. Inhibition of platelet adhesion to surfaces of extracorporeal circuits by disintegrins: RGD-containing peptides from viper venoms. Circulation, 1990, 82, 261-273.
133. Gould, R. J., Polokoff, M. A., Friedman, P. A., Huang, T. F., Holt, J. C., Cook, J. J., Niewiarowski, S. Mini review. Disintegrins: a family of integrin inhibitory proteins from viper venoms. Proc. Soc. Exptl. Biol. Med., 1990, 195, 168-171.
134. Kini, R. M., Evans, H. J. Structural domains in venom proteins: evidence that metalloproteinases and nonenzymatic platelet aggregation inhibitors (disintegrins) from snake venoms are derived by proteolysis from a common precursor. Toxicon, 1992, 30, 265-293.
135. Hite, L. A., Shannon, J. D., Bjarnason, J. B., Fox, J. W. Sequence of a cDNA clone encoding the zinc metalloproteinase hemorrhagic toxin e from Crotalus atrox: evidence for signal, zymogen, and disintegrin-like structures. Biochemistry, 1992, 31 6203-6211.
136. Hite, L. A., Bjarnason, J. B., Fox, J. W. cDNA sequences for four snake venom metalloproteinases: structure, classification, and their relationship to mammalian reproductive proteins. Arch. Biochem. Biophys., 1994, 308, 182-191.
137. Takeya, H., Nishida, S., Miyata, T., Kawada, S., Saisaka, Y., Morita, T., Iwanaga, S. Coagulation factor X activating enzyme from Russell's viper venom (RVV-X). A novel metalloproteinase with disintegrin (platelet aggregation inhibitor)-like and C-type lectin-like domains. J. Biol. Chem., 1992, 267, 14109-14117.
138. Takeya, H., Nishida, S., Nishino, N., Makinose, Y., Omori-Satoh, T., Nikai, T., Sugihara, H., Iwanaga, S. Primary structures of platelet aggregation inhibitors (disintegrins) autoproteolytically released from snake venom hemorrhagic metalloproteinases and new fluorogenic peptide substrates for these enzymes. J. Biochem., 1993, 113, 473-483.
139. Paine, M. J. I., Desmond, H. P., Theakston, R. D. G., Crampton, J. M. Purification, cloning, and molecular characterization of a high molecular weight hemorrhagic metalloproteinase, jararhagin, from Bothrops jararaca venom. Insights into the disintegrin gene family. J. Biol. Chem., 1992, 267, 22869-22876.
140. Paine, M. J. I., Moura-de-Silva, A. M., Theakston, R. D. G., Crampton, J. M. Cloning of metalloproteinase genes in the carpet viper (Echis pyramidum leakeyi). Further members of the metalloprotease/disintegrin gene family. Eur. J. Biochem., 1994 224, 483-488.
141. Au, L. C., Chou, J. S., Chang, K. J., Teh, G. W., Lin, S. B. Nucleotide sequence of a full-length cDNA encoding a common precursor of platelet aggregation inhibitor and hemorrhagic protein from Calloselasma rhodostoma venom. Biochim. Biophys. Acta, 1993 1173, 243-245.
142. Scarborough, R. M., Rose, J. W., Hsu, M. A., Phillips, D. R., Fried, V. A., Campbell, A. M., Nannizzi, L., Charo, I. F. Barbourin. A GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri. J. Biol. Chem., 1991, 266, 9359-9362.
143. Oshikawa, K., Terada, S. Ussuristatin 2, a novel KGD-bearing disintegrin from Agkistrodon ussuriensis venom. J. Biochem., 1999, 125, 31-35.
144. Okuda, D., Morita, T. Purification and characterization of a new RGD/KGD-containing dimeric disintegrin, piscivostatin, from the venom of Agkistrodon piscivorus piscivorus: the unique effect of piscivostatin on platelet aggregation. J. Biochem., 2001, 130, 407-415.
145. Scarborough, R. M., Naughton, M. A., Teng, W., Rose, J. W., Phillips, D. R., Nannizzi, L., Arfsten, A., Campbell, A. M., Charo, I. F. Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa. J. Biol. Chem., 1993, 268, 1066-1073.
146. Adler, M., Lazarus, R. A., Dennis, M. S., Wagner, G. Solution structure of kistrin, a potent platelet aggregation inhibitor and GP IIb-IIIa antagonist. Science, 1991, 253, 445-448.
147. Saudek, V., Atkinson, R. A., Pelton, J. T. Three-dimensional structure of echistatin, the smallest active RGD protein. Biochemistry 1991, 30, 7369-7372.
148. Cooke, R. M., Carter, B. G., Murray-Rust, P., Hartshorn, M. J., Herzyk, P., Hubbard, R. E. The solution structure of echistatin: evidence for disulfide bond rearrangement in homologous snake toxins. Protein Engg., 1992, 5, 473-477.
149. Senn, H., Klaus, W. The nuclear magnetic resonance solution structure of flavoridin, an antagonist of the platelet GP IIb-IIIa receptor. J. Mol. Biol., 1993, 232, 907-925.
150. 1H NMR spectroscopy and simulated annealing calculations. Int. J. Pept. Protein Res., 1996, 48, 220-228.
151. 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins. Biochem. J., 1994, 304, 929-936.
152. Lu, X., Rahman, S., Kakkar, V. V., Authi, K. S. Substitutions of Proline 42 to Alanine and Methionine 46 to Asparagine around RGD domain of the neurotoxin dendroaspin alter its preferential antagonism to that resembling the disintegrin elagantin. J. Biol. Chem., 1996 271, 289-294.
153. Lu, X., Sun, Y., Shang, D., Wattam, B., Egglezou, S., Hughes, T., Hyde, E., Scully, M., Kakkar, V. Evaluation of the role of Proline residues flanking the RGD motif of dendroaspin, an inhibitor of platelet aggregation and cell adhesion. Biochem. J., 2001, 355, 633-638.
154. 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD. Biochem. J. 1995, 312, 223-232.
155. McLane, M. A., Vijay-Kumar, S., Marcinkiewicz, C., Calvete, J. J., Niewiarowski, S. Importance of the structure of the RGD-containing loop in the disintegrins echistatin and eristostatin for the recognition of αIIβ3 and αvβ3 integrins. FEBS Lett., 1996, 391, 139-143.
156. Smith, J. B., Theakston, R. D. G., Coelho, A. L. J., Barja-Fidalgo, C., Calvete, J. J., Marcinkiewicz, C. Characterization of a monomeric disintegrin, ocellatusin, present in the venom of the Nigerian carpet viper, Echis ocellatus. FEBS Lett., 2002, 512, 111-115.
157. 3. FEBS Lett., 1996, 387 11-15.
158. Proimos, G. Platelet aggregation inhibition with glycoprotein IIb - IIIa inhibitors. J. Thromb. Thrombolysis, 2001, 11 99-110.
159. Phillips, D. R., Scarborough, R. M. Clinical pharmacology of eptifibatide. Am. J. Cardiol., 1997, 80 (Suppl. 4A), 11B-20B.
160. Deckelbaum, L. I., Sax, F. L., Grossman, W. In New Therapeutic Agents in Thrombosis and Thrombolysis; Sasahara, A. A., Loscalzo, J., Eds.; Marcel Dekker; New York, NY, 1997, pp. 355-365.
161. Sheu, J. R., Lin, C. H., Huang, T. F. Triflavin, an antiplatelet peptide inhibits tumor cell-extracellular matrix adhesion via an RGD-dependent mechanism. J. Lab. Clin. Med., 1994, 123, 256-263.
162. Lefkovits, J., Topol, E. J. Platelet glycoprotein IIb/IIIa receptor antagonists in coronary artery disease. Eur. Heart J., 1996, 17, 9-18.
163. Sheu, J. R., Lin, C. H., Peng, H. C., Huang, T. F. Triflavin, an Arg-Gly-Asp containing peptide, inhibits the adhesion of tumor cells to matrix proteins via binding to multiple integrin receptors expressed on human hepatoma cells. Proc. Soc. Exp. Biol. Med., 1996, 213, 71-79.
164. Chiang, H. S., Yang, R. S., Huang, T. F. Arg-Gly-Asp containing peptide, rhodostomin, inhibits in vitro cell adhesion to extracellular matrices and platelet aggregation caused by Sao-2 human osteosarcoma cells. Br. J. Cancer, 1995, 71, 265-270.
165. Soszka, T., Knudsen, K. A., Beviglia, L., Rossi, C., Poggi, A., Niewiarowski, S. Inhibition of routine melanoma cell-matrix adhesion and experimental metastasis by albolabrin, an RGD-containing peptide isolated from the venom of Trimeresurus albolabris. Exp. Cell Res., 1991, 196, 6-12.
166. Sheu, J. R., Lin, C. H., Chuang, J. L., Teng, C. M., Huang, T. F. Triflavin, an Arg-Gly-Asp containing peptide inhibits cell-substratum adhesion and melanoma cell-induced lung colonization. Jpn. J. Cancer Res., 1992, 83, 885-893.
167. 1 integrin-mediated human metastatic melanoma cell adhesion and blocks experimental metastasis. Cancer Res., 1994, 54, 4993-4998.
168. Morris, V. L., Schmidt, E. E., Koop, S., MacDonald, I. C., Grattan-Khokka, R., McLane, M. A., Niewiarowski, S., Chambers, A. F., Croom, A. C. Effects of disintegrin eristostatin on individual steps of hematogenous metastasis. Exp. Cell Res., 1995, 219, 571-578.
169. Sheu, J. R., Lin, C. H., Chuang, J. L., Teng, C. M., Huang, T. F. Triflavin, an Arg-Gly-Asp containing peptide, inhibits aggregation of human platelets induced by human hepatoma cell line. Thrombos. Res. 1992, 66, 679-691.
170. 3 integrin monoclonal antibody. Biochim. Biophys. Acta, 1997, 1336, 445-454.
171. 3 antagonist and inducing apoptosis. Blood, 1998 92, 3268-3276.
172. Hong, S. Y., Koh, Y. S., Chung, K. H., Kim, D. S. Snake venom disintegrin, saxatilin, inhibits platelet aggregation, human umbilical vein endothelial cell proliferation, and smooth muscle cell migration. Thrombos, Res., 2002, 105, 79-86.
173. Dresner-Pollak, R., Rosenblatt, M. Blockade of osteoclast-mediated bone resorption through occupancy of the integrin receptor: a potential approach to the therapy of osteoporosis. J. Cell. Biochem., 1994, 56, 323-330.
174. 3 receptor. J. Pharmacol. Exp. Ther., 1997, 283, 843-853.
175. Yamamoto, M., Fisher, J. E., Gentile, M., Seedor, J. G., Leu, C. T., Rodan, S. B., Rodan, G. A. The integrin ligand echistatin prevents bone loss in ovariectomized mice and rats. Endocrinology, 1998 139, 1411-1419.
176. Masarachia, P., Yamamoto, M., Len, C. T., Rodan, G., Duong, L. Histomorphometric evidence for echistatin inhibition of bone resorption in mice with secondary hyperparathyroidism. Endocrinology 1998, 139, 1401-1410.
177. McLane, M. A., Sanchez, E. E., Wong, A., Paquette-Straub, C., Perez, J. C. Disintegrins. Curr. Drug Targets - Cardiovasc. Hemat. Disorders, this issue.
178. McDowell, R. S., Dennis, M. S., Louie, A., Shuster, M., Mulkerrin, M. G., Lazarus, R. A. Mambin, a potent glycoprotein IIb-IIIa antagonist and platelet aggregation inhibitor structurally related to the short neurotoxins. Biochemistry, 1992, 31, 4766-4772.
179. Sutcliffe, M. J., Jaseja, M., Hyde, E. I., Lu, X., Williams, J. A. Three-dimensional structure of the RGD-containing neurotoxin homologue dendroaspin. Nat. Struct. Biol., 1994, 1, 802-807.
180. Kini, R. M. Molecular molds with multiple missions: functional sites in three-finger toxins. Clinic. Exptl. Pharmacol. Physiol., 2002, 29, 815-822.
181. Seymour, J. L., Henzel, W. J., Nevins, B., Stults, J. T., Lazarus, R. A. Decorsin. A potent glycoprotein IIb-IIIa antagonist and platelet aggregation inhibitor from the leech Macrobdella decora. J. Biol. Chem., 1990, 265, 10143-10147.
182. Mazur, P., Henzel, W. J., Seymour, J. L., Lazarus, R. A. Ornatins: potent glycoprotein IIb-IIIa antagonists and platelet aggregation inhibitors from the leech Placobdella ornata. Eur. J. Biochem., 1991, 202, 1073-1082.
183. Krezel, A. M., Wagner, G., Seymour-Ulmer, J., Lazarus, R. A. Structure of the RGD protein decorsin: conserved motif and distinct function in leech proteins that affect blood clotting. Science, 1994, 264, 1944-1947.
184. Karczewski, J., Endris, R., Connolly, T. M. Disagregin is a fibrinogen receptor antagonist lacking the Arg-Gly-Asp sequence from the tick, Ornithodoros moubata. J. Biol. Chem., 1994, 269, 6702-6708.
185. Mans, B. J., Louw, A. I., Neitz, A. W. H. Savignygrin, a platelet aggregation inhibitor from the soft tick Ornithodoros savignyi, presents the RGD integrin recognition motif on the kunitz-BPTI fold. J. Biol. Chem., 2002, 277, 21371-21378.
186. Wang, X., Coons, L. B., Taylor, D. B., Stevens, S. E. Jr., Gartner, T. K. Variabilin, a novel RGD-containing antagonist of glycoprotein IIb-IIIa and platelet aggregation inhibitor from the hard tick Dermacentor variabilis. J. Biol. Chem., 1996, 271, 17785-17790.
187. Girma J.-P., Meyer, D., Verweij, C. L., Pannekoek, H., Sixma, J. J. Structure-function relationship of human von Willebrand factor. Blood, 1987, 70, 605-611.
188. Sadler, J. E. von Willebrand factor. J. Biol. Chem., 1991, 266, 18172-18178.
189. Peng, M., Holt, J. C., Niewiarowski, S. Isolation, characterization and amino acid sequence of echicetin β subunit, a specific inhibitor of von Willebrand factor and thrombin interaction with glycoprotein Ib. Biochem. Biophys. Res. Commun., 1994, 205 68-72.
190. Peng, M., Emig, F. A., Mao, A., Lu, W., Kirby, E. P., Niewiarowski, S., Kowalska, M. A. Interaction of echicetin with a high affinity thrombin binding site on platelet glycoprotein GPIb. Thromb. Haemost., 1995, 74, 954-957.
191. Morita, T. C-type lectin-related proteins. Current Drug Targets, this issue.
192. Mizuno, H., Fujimoto, Z., Atoda, H., Morita, T. Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X. Proc. Natl. Acad. Sci. U S. A., 2001, 98, 7230-7234.
193. Fukuda, K., Doggett, T. A., Bankston, L. A., Cruz, M. A., Diacovo, T. G., Liddington, R. C. Structural basis of von Willebrand factor activation by the snake toxin botrocetin. Structure, 2002 10, 943-950.
194. Maita, N., Nishio, K., Nishimoto, E., Matsui, T., Shikamoto, Y., Morita, T., Sadler, J. E., Mizuno, H. Crystal structure of von Willebrand factor A1 domain complexed with snake venom, bitiscetin: insight into glycoprotein Ibα binding mechanism induced by snake venom proteins. J. Biol. Chem., 2003, 278, 37777-37781.
195. Mizuno, H., Fujimoto, Z., Koizumi, M., Kano, H., Atoda, H., Morita, H. Structure of Coagulation factors IX/X-binding protein, a heterodimer of C-type lectin domains. Nature Struc. Biol., 1997 4, 438-441.
196. Hirotsu, S., Mizuno, H., Fukuda, K., Qi, M. C., Matsui, T., Hamako, J., Morita, T., Titani, K. Crystal structure of bitiscetin, a von Willebrand factor-dependent platelet aggregation inducer. Biochemistry 2001, 40, 13592-13597.
197. Sixma, J. J., van Zanten, G. H., Saelman, E. U., Verkleij, M., Lankhof, H., Nieuwenhuis, H. K., de Groot, P. G. Platelet adhesion to collagen. Thromb. Haemost., 1995, 74, 454-459.
198. Munro, R., Jones, C. P., Sawyer, R. T. Calin - a platelet adhesion inhibitor from the saliva of the medicinal leech. Blood Coagul. Fibrinolysis, 1991, 2, 179-184.
199. Connolly, T. M., Jacobs, J. W., Condra, C. An inhibitor of collagen-stimulated platelet activation from the salivary glands of the Haementeria officinalis leech. I. Identification, isolation, and characterization. J. Biol. Chem., 1992, 267, 6893-6898.
200. Keller, P. M., Schultz, L. D., Condra, C., Karczewski, J., Connolly, T. M. An inhibitor of collagen-stimulated platelet activation from the salivary glands of the Haementeria officinalis leech. II. Cloning of the cDNA and expression. J. Biol. Chem., 1992, 267, 6899-6904.
201. Keller, P. M., Waxman, L., Arnold, B. A., Schultz, L. D., Condra, C., Connolly, T. M. Cloning of the cDNA and expression of moubatin, an inhibitor of platelet aggregation. J. Biol. Chem., 1993, 268, 5450-5456.
202. Waxman, L., Connolly, T. M. Isolation of an inhibitor selective for collagen-stimulated platelet aggregation from the soft tick Ornithodoros moubata. J. Biol. Chem., 1993, 268, 5445-5449.
203. Usami, Y., Fujimura, Y., Miura, S., Shima, H., Yoshida, E., Yoshioka, A., Hirano, K., Suzuki, M., Titani, K. A 28 kDa-protein with disintegrin-like structure (jararhagin-C) purified from Bothrops jararaca venom inhibits collagen- and ADP-induced platelet aggregation. Biochem. Biophys. Res. Commun., 1994, 201, 331-339.
204. Karczewski, J., Waxman, L., Endris, R. G., Connolly, T. M. An inhibitor from the argasid tick Ornithodoros moubata of cell adhesion to collagen. Biochem. Biophys. Res. Commun., 1995, 208, 532-541.
205. Zhou, Q., Dangelmaier, C., Smith, J. B. The hemorrhagin catrocollastatin inhibits collagen-induced platelet aggregation by binding to collagen via its disintegrin-like domain. Biochem. Biophys. Res. Commun., 1996, 19,720-726.
206. Shimokawa, K., Shannon, J. D., Jia, L. G., Fox, J. W. Sequence and biological activity of catrocollastatin-C: a disintegrin-like/cysteine-rich two-domain protein from Crotalus atrox venom. Arch. Biochem. Biophys., 1997, 343, 35-43.
207. Liu, C. Z., Huang, T. F. Crovidisin, a collagen-binding protein isolated from snake venom of Crotalus viridis, prevents platelet-collagen interaction. Arch. Biochem. Biophys., 1997, 337, 291-299.
208. Noeske-Jungblut, C., Krätzschmar, J., Haendler, B., Alagon, A., Possani, L., Verhallen, P., Donner, P., Schleuning, W. D. An inhibitor of collagen-induced platelet aggregation from the saliva of Triatoma pallidipennis. J. Biol. Chem., 1994, 269, 5050-5053.
209. Haendler, B., Becker, A., Noeske-Jungblut, C., Krätzschmar, J., Donner, P., Schleuning, W. D. Expression of active recombinant pallidin, a novel platelet aggregation inhibitor, in the periplasm of Escherichia coli. Biochem. J., 1995, 307, 465-470.
210. Jia, L. G., Wang, X. M., Shannon, J. D., Bjarnason, J. B., Fox, J. W. Function of disintegrin-like/cysteine-rich domains of atrolysin A. Inhibition of platelet aggregation by recombinant protein and peptide antagonists. J. Biol. Chem., 1997, 272, 13094-13102.
211. Kamiguti, A. S., Moura da Silva, A. M., Laing, G. D., Knapp, T., Zuzel, M., Crampton, J. M., Theakston, R. D. Collagen-induced secretion-dependent phase of platelet aggregation is inhibited by the snake venom metalloproteinase jararhagin. Biochim. Biophys. Acta, 1997, 1335, 209-217.
212. 1-integrin by the snake venom metalloproteinase jararhagin. Biochem. J., 1996, 320, 635-641.
213. Fenton, J. W., Ofosu, F. A., Moon, D. G., Maraganore, J. M. Thrombin structure and function: why thrombin is the primary target for antithrombotics. Blood Coagul. Fibrinolysis, 1991, 2, 69-75.
214. Zingali, R. B., Jandrot-Perrus, M., Guillin, M. C., Bon, C. Bothrojaracin, a new thrombin inhibitor isolated from Bothrops jararaca venom: characterization and mechanism of thrombin inhibition. Biochemistry, 1993, 32, 10794-10802.
215. Castro, H. C., Dutra, D. L., Oliveira-Carvalho, A. L., Zingali, R. B. Bothroalternin, a thrombin inhibitor from the venom of Bothrops alternatus. Toxicon, 1998, 36, 1903-1912.
216. Noeske-Jungblut, C., Haendler, B., Donner, P., Alagon, A., Possani, L., Schleuning, W. D. Triabin, a highly potent exosite inhibitor of thrombin. J. Biol. Chem., 1995, 270, 28629-28634.
217. Fuentes-Prior, P., Noeske-Jungblut, C., Donner, P., Schleuning, W. D., Huber, R., Bode, W. Structure of the thrombin complex with triabin, a lipocalin-like exosite-binding inhibitor derived from a triatomine bug. Proc. Natl. Acad. Sci. U. S. A., 1997, 94 11845-11850.
218. Glusa, E., Bretschneider, E., Daum, J., Noeske-Jungblut, C. Inhibition of thrombin-mediated cellular effects by triabin, a highly potent anion-binding exosite thrombin inhibitor. Thromb. Haemost., 1997, 77, 1196-1200.
219. Monteiro, R. Q., Raposo, J. G., Wisner, A., Guimaraes, J. A., Bon, C., Zingali, R. B. Allosteric changes of thrombin catalytic site induced by interaction of bothrojaracin with anion-binding exosites I and II. Biochem. Biophys. Res. Commun., 1999, 262, 819-822.
220. Zingali, R. B., Bianconi, M. L., Monteiro, R. Q. Interaction of bothrojaracin with prothrombin. Haemostasis, 2001, 31 273-278.
221. Barbouche, R., Marrakchi, N., Mansuelle, P., Krifi, M., Fenouillet, E., Rochat, H., El Ayeb, M. Novel anti-platelet aggregation polypeptides from Vipera lebetina venom: isolation and characterization. FEBS Lett., 1996, 392, 6-10.
222. Barbouche, R., Marrakchi, N., Mabrouk, K., Krifi, M. N., Van Rietschoten, J., Fenouillet, E., El Ayeb, M., Rochat, H. Anti-platelet activity of the peptides composing the lebetin 1 family, a new class of inhibitors of platelet aggregation. Toxicon, 1998. 36, 1939-1947.
223. Marrakchi, N., Mabrouk, K., Regaya, I., Sarray, S., Fathallah, M., Rochat, H., El Ayeb, M. Lebetin peptides: potent platelet aggregation inhibitors. Haemostasis, 2001, 31, 207-210.
224. Joseph, R., Pahari, S., Hodgson, W. C., Kini, R. M. Hypotensive agents from snake venoms. Curr. Drug Targets - Cardiovasc. Hemat. Disorders, this issue.
225. Ouyang, C., Huang, T. F. Inhibition of platelet aggregation by 5′-nucleotidase purified from Trimeresurus gramineus snake venom. Toxicon, 1983, 21, 491-501.
226. Ouyang, C., Huang, T. F. Platelet aggregation inhibitors from Agkistrodon acutus snake venom. Toxicon, 1986, 24 1099-1106.
227. Boffa, M. C., Boffa, G. A. Correlations between the enzymatic and factors active on blood coagulation and platelet aggregation from the venom of Vipera aspis. Biochim. Biophys. Acta, 1974, 354 275-290.
228. 2 Enzymes: Structure, Function and Mechanism; Kini, R. M., Ed.; John Wiley: Chichester, 1997; pp. 369-387.
229. 2. Blood, 1995, 86, 4166-4174.
230. Ouyang, C., Yeh, H. I., Huang, T. F. A potent platelet aggregation inhibitor purified from Agkistrodon halys (mamushi) snake venom. Toxicon, 1983, 21, 797-804.
231. 2 isoenzymes, from Naja nigricollis venom. Thromb. Haemost., 1988, 60, 170-173.
232. 2 from the venom of the Papuan black snake (Pseudechis papuanus). Biochim. Biophys. Acta, 1995, 1250, 137-143.
233. 2 from Ophiophagus hannah snake venom. Life Sci., 1997, 61, 2211-2217.
234. Ouyang, C., Teng, C. M. Fibrinogenolytic enzymes of Trimeresurus venom. Biochim. Biophys. Acta, 1976, 420 298-308.
235. Ouyang, C., Teng, C. M., Chen, Y. C. Properties of fibrinogen degradation products produced by α- and β- fibrinogenases of Trimeresurus mucrosquamatus snake venom. Toxicon, 1979, 17, 121-126.
236. Kini, R. M., Evans, H. J. Inhibition of platelet aggregation by a fibrinogenase from Naja nigricollis venom is independent of fibrinogen degradation. Biochim. Biophys. Acta, 1991, 1095 117-121.
237. Huang, T. F., Chang, M. C., Teng, C. M. Antiplatelet protease, kistomin, selectively cleaves human platelet glycoprotein Ib. Biochim. Biophys. Acta, 1993, 1158, 293-299.
238. Wu, W. B., Peng, H. C., Huang, T. F. Crotalin, a vWF and GP Ib cleaving metalloproteinase from venom of Crotalus atrox. Thromb. Haemost., 2001, 86, 1501-1511.
239. Shimokawa, K., Jia, L. G., Shannon, J. D., Fox, J. W. Isolation, sequence analysis, and biological activity of atrolysin E/D the non-RGD disintegrin domain from Crotalus atrox venom. Arch. Biochem. Biophys., 1998, 354, 239-246.
240. Chow, G., Kini, R. M. Exogenous factors from animal sources that induce platelet aggregation. Thrombos. Haemostas., 2001, 85, 177-178.
241. Schmaier, A. H., Claypool, W., Colman, R. W. Crotalocytin: recognition and purification of a timber rattlesnake platelet aggregating protein. Blood, 1980, 56, 1013-1019.
242. Schmaier, A. H., Colman, R. W. Crotalocytin: characterization of the timber rattlesnake platelet activating protein. Blood, 1980, 56, 1020-1028.
243. Hill-Eubanks, D. C., Parker, C. G., Lollar, P. Differential proteolytic activation of factor VIII-von Willebrand factor complex by thrombin. Proc. Natl. Acad. Sci. U. S. A., 1989, 86, 6508-6512.
244. Niewiarowski, S., Kirby, E. P., Stocker, K. Thrombocytin - a novel platelet activating enzyme from Bothrops atrox venom. Thromb. Res., 1977, 10, 863-869.
245. Kirby, E. P., Niewiarowski, S., Stocker, K., Kettner, C., Shaw, E., Budzynski, T, M. Thrombocytin, a serine protease from Bothrops atrox venom. 1. Purification and characterization of the enzyme. Biochemistry, 1979, 18, 3564-3570.
246. Niewiarowski, S., Kirby, E. P., Brudzynski, T. M., Stocker. K. Thrombocytin, a serine protease from Bothrops atrox venom. 2. Interaction with platelets and plasma-clotting factors. Biochemistry 1979, 18, 3570-3577.
247. Kubisz, P., Arabi, A., Seghier, F., Cronberg, S. Investigations on the effect of thrombocytin on platelets. Thromb. Res., 1984, 33, 225-227.
248. Herzig, R. H., Ratnoff, O. D., Shainoff, J, R. Studies on a procoagulant fraction of southern copperhead snake venom: the preferential release of fibrinopeptide B. J. Lab. Clin. Med., 1970, 76, 451-465.
249. Davey, M. G., Luscher, E. F. Actions of some coagulant snake venom on blood platelets. Nature, 1965, 207, 730-732.
250. Mebs, D., Holada, K., Kornalik, F., Simak, J., Vanková, H., Muller, D., Schoenemann, H., Lange, H., Herrmann, H. W. Severe coagulopathy after a bite of a green bush viper (Atheris squamiger : case report and biochemical analysis of the venom. Toxicon, 1998, 36, 1333-1340.
251. Brink, S., Steytler, J. G. Effects of puff-adder venom on coagulation, fibrinolysis and platelet aggregation in the baboon. S. Afr. Med. J., 1974, 48, 1205-1213.
252. Phillips, L. L., Weiss, H. J., Pessar, L., Christy, N. P. Effects of puff adder venom on the coagulation mechanism. I. In vivo. Toxicon, 1973, 11, 423-431.
253. Phillips, L. L., Weiss, H. J., Christy, N. P. Effects of puff adder venom on the coagulation mechanism. II. In vitro. Thromb. Diath. Haemorrh., 1973, 30, 499-508.
254. MacKay, N., Ferguson, J. C., McNicol, G. P. Effects of the venom of the rhinoceros horned viper (Bitis nasicornis) on blood coagulation, platelet aggregation, andfibrinolysis. J. Clin. Pathol. 1970, 23, 789-796.
255. Hardy, D. L., Jeter, M., Corrigan, J. J., Jr., Envenomation by the Northern black tail rattlesnake (Crotalus molossus molossus : report of two cases and the in vitro effects of the venom on fibrinolysis and platelet aggregation. Toxicon, 1982, 20 487-493.
256. Marshall, L. R., Herrmann, R. P. Australian snake venoms and their in vitro effect on human platelets. Thromb. Res., 1989, 54, 269-275.
257. Mitrakul, C. Effects of green pit viper (Trimeresurus erythrurus and Trimeresurus popeorum) venoms on blood coagulation, platelets and the fibrinolytic enzyme systems: studies in vivo and in vitro. Am. J. Clin. Pathol., 1973, 60, 654-662.
258. Iddon, D., Theakston, R. D. Biological properties of the venom of the red-necked keel-back snake (Rhabdophis subminiatus). Ann. Trop. Med. Parasitol., 1986, 80, 339-344.
259. Williams, J, Rucinski, B., Holt, J., Niewiarowski, S. Elegantin and albolabrin purified peptides from viper venoms: homologies with the RGDS domain of fibrinogen and von Willebrand factor. Biochim. Biophys. Acta, 1990, 1039, 81-89.
260. Chao, B. H., Jakubowski, J. A., Savage, B., Chow, E. P., Marzec, U. M., Harker, L. A., Maraganore, J. M. Agkistrodon piscivorus piscivorus platelet aggregation inhibitor: a potent inhibitor of platelet activation. Proc. Natl. Acad. Sci. U. S. A., 1989, 86, 8050-8054.
261. Savage, B., Marzec, U. M., Chao, B. H., Harker, L. A., Maraganore, J. M., Ruggeri, Z. M. Binding of the snake venom-derived proteins applaggin and echistatin to the arginine-glycine-aspartic acid recognition site(s) on platelet glycoprotein IIb-IIIa complex inhibits receptor function. J. Biol. Chem., 1990, 265, 11766-11772.
262. Huang, T. F., Wang, W. J., Teng, C. M., Liu, C. S., Ouyang, C. Purification and characterization of an antiplatelet peptide, arietin, from Bitis arietans venom. Biochim. Biophys. Acta, 1991 1074, 136-143.
263. Huang, T. F., Wang, W. J., Teng, C. M., Ouyang, C. Mechanism of action of the antiplatelet peptide, arietin, from Bitis arietans venom. Biochim. Biophys. Acta, 1991, 1074, 144-150.
264. Rucinski, B., Niewiarowski, S., Holt, J. C., Soszka, T., Knudsen, K. A. Batroxostatin, an Arg-Gly-Asp-containing peptide from Bothrops atrox, is a potent inhibitor of platelet aggregation and cell interaction with fibronectin. Biochim. Biophys. Acta, 1990, 1054, 257-262.
265. Dennis, M. S., Henzel, W. J., Pitti, R. M., Lipari, M. T., Napier, M. A., Deisher, T. A, Bunting, S., Lazarus, R. A. Platelet glycoprotein IIb-IIIa protein antagonists from snake venoms: Evidence for a family of platelet-aggregating inhibitors. Proc. Natl. Acad. Sci. U. S. A., 1990, 87, 2471-2475.
266. Shebuski, R. J., Ramjit, D. R., Bencen, G. H., Polokoff, M. A. Characterization and platelet inhibitory activity of bitistatin, a potent arginine-glycine-aspartic acid-containing peptide from the venom of the viper Bitis arietans. J. Biol. Chem., 1989, 264, 21550-21556.
267. Marrakchi, N., Barbouche, R., Bon, C., El Ayeb, M. Cerastatin, a new potent inhibitor of platelet aggregation from the venom of the Tunisian viper, Cerastes cerastes. Toxicon, 1997, 35, 125-135.
268. Liu, C. Z., Peng, H. C., Huang, T. F. Crotavirin, a potent platelet aggregation inhibitor purified from the venom of the snake Crotalus viridis. Toxicon, 1995, 33, 1289-1298.
269. McLane, M. A., Kowalska, M. A., Silver, L., Shattil, S. J., Niewiarowski, S. Interaction of disintegrins with the alpha IIb beta 3 receptor on resting and activated human platelets. Biochem. J., 1994, 301, 429-436.
270. McLane, M. A., Gabbeta, J., Rao, A. K., Beviglia, L., Lazarus, R. A., Niewiarowski, S. A comparison of the effect of decorsin and two disintegrins, albolabrin and eristostatin, on platelet function. Thromb. Haemost., 1995, 74, 1316-1322.
271. Kawasaki, T., Sakai, Y., Taniuchi, Y., Sato, K,, Maruyama, K., Shimizu, M., Kaku, S., Yano, S., Inagaki, O., Tomioka, K., Yanagisawa, L, Takenaka, T. Biochemical characterization of a new disintegrin, flavostatin, isolated from Trimeresurus flavoviridis venom. Biochimie, 1996, 78, 245-252.
272. Maruyama, K., Kawasaki, T., Sakai, Y., Taniuchi, Y., Shimizu, M., Kawashima, H., Takenaka, T. Isolation and amino acid sequence of flavostatin, a novel disintegrin from the venom of Trimeresurus flavoviridis. Peptides, 1997, 18, 73-78.
273. Huang, T. F., Peng, H. C., Peng, I. S., Teng, C. M., Ouyang, C. An antiplatelet peptide, gabonin, from Bitis gabonica snake venom. Arch. Biochem. Biophys., 1992, 298, 13-20.
274. Huang, T. F., Liu, C. Z., Ouyang, C. H., Teng, C. M. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist. Biochem. Pharmacol., 1991, 42, 1209-1219.
275. Trikha, M., Rote, W. E., Manley, P. J., Lucchesi, B. R., Markland, F. S. Purification and characterization of platelet aggregation inhibitors from snake venoms. Thromb. Res., 1994, 73, 39-52.
276. Kang, I. C., Chung, K. H., Lee, S. J., Yuri, Y., Moon, H. M., Kim, D. S. Purification and molecular cloning of a platelet aggregation inhibitor from the snake (Agkistrodon halys brevicaudus) venom. Thromb. Res., 1998, 91, 65-73.
277. Park, D., Kang, I., Kim, H., Chung, K., Kim, D. S., Yun, Y. Cloning and characterization of novel disintegrins from Agkistrodon halys venom. Mol. Cells, 1998, 8, 578-584.
278. Huang, T. F., Sheu, J. R., Teng, C. M. A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom. Biochem. J., 1991, 277, 351-357.
279. Huang, T. F., Sheu, J. R., Teng, C. M., Chen, S. W., Liu, C. S. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex. J. Biochem., 1991, 109, 328-334.
280. Huang, T. F., Holt, J. C., Lukasiewicz, H., Niewiarowski, S. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex. J. Biol. Chem., 1987, 262, 16157-16163.
281. Tsai, I. H., Wang, Y. M., Lee, Y. H. Characterization of a cDNA encoding the precursor of platelet aggregation inhibition and metalloproteinase from Trimeresurus mucrosquamatus venom. Biochim. Biophys. Acta, 1994, 1200, 337-340.
282. Huang, T. F., Wu, Y. J., Ouyang, C. Characterization of a potent platelet aggregation inhibitor from Agkistrodon rhodostoma snake venom. Biochim. Biophys. Acta, 1987, 925, 248-257.
283. Grevelink, S. A., Youssef, D. E., Loscalzo, J., Lerner, E. A. Salivary gland extracts from the deerfly contain a potent inhibitor of platelet aggregation. Proc. Natl. Acad. Sci. U. S. A., 1993, 90, 9155-9158.
284. Scarborough, R. M., Hsu, M. A., Teng, W., Nannizzi, L., Rose, J. W. Purification and characterization of potent inhibitors of von Willebrand factor binding to glycoprotein (GP) 1b from the venom of timber rattlesnake, Crotalus h. horridus. Blood, 1991, 78 1568.
285. Kawasaki, T., Fujimura, Y., Usami, Y., Suzuki, M., Miura, S., Sakurai, Y., Makita, K., Taniuchi, Y., Hirano, K.. Titani, K. Complete amino acid sequence and identification of the platelet glycoprotein Ib-binding site of jararaca GPIb-BP, a snake venom protein isolated from Bothrops jararaca. J. Biol. Chem., 1996, 271, 10635-10639.
286. Chow, G., Subburaju, S., Kini, R. M. Purification, characterization, and amino acid sequence determination of acanthins, potent inhibitors of platelet aggregation from Acanthophis antarcticus (common death adder) venom. Arch. Biochem. Biophys., 1998, 354, 232-238.
287. Sim, K. L. Purification and preliminary characterisation of praelongin phospholipases, antiplatelet agents from the snake venom of Acanthophis praelongus. Biochim. Biophys. Acta, 1998, 1379 198-206.
288. Huang, T. F., Yeh, H. I., Ouyang, C. Mechanism of action of the platelet aggregation inhibitor purified from Agkistrodon halys (mamushi) snake venom. Toxicon, 1984, 22, 243-251.
289. 2 from the venom of Agkistrodon halys pallas. Toxicon, 1987 25, 401-409.
290. 2: a potent inhibitor of platelet aggregation. Thromb. Res., 1993, 70, 471-481.
291. Subburaju, S., Kini, R. M. Isolation and purification of superbins I and II from Austrelaps superbus (copperhead) snake venom and their anticoagulant and antiplatelet effects. Toxicon, 1997, 35, 1239-1250.
292. 2 with platelet aggregation inhibitor activity from Austrelaps superbus venom: protein purification and cDNA cloning. Arch. Biochem. Biophys., 2000, 375, 289-303.
293. 2 from Bothrops jararacussu snake venom. Biochem. Pharmacol., 2002, 64 723-732.
294. 2 from Indian saw-scaled viper (Echis carinatus) venom. Toxicon, 1999, 37, 1659-1671.
295. 2 isolated from Lachesis muta (Bushmaster) snake venom. Thromb. Haemost., 1997, 78, 1372-1380.
296. 2 from the venom of Ophiophagus hannah (King cobra): a novel cobra venom enzyme with "pancreatic loop" . Arch. Biochem. Biophys., 1997, 338, 150-156.
297. Ouyang, C., Huang, T. F. Potent platelet aggregation inhibitor from Trimeresurus gramineus snake venom. Biochim. Biophys. Acta, 1983, 757, 332-341.
298. Huang, T. F., Ouyang, C. Action mechanism of the potent platelet aggregation inhibitor from Trimeresurus gramineus snake venom. Thromb. Res., 1984, 33, 125-138.
299. 2. J. Nat. Toxins, 2002, 11, 25-33.
300. Prasad, B. N., Kemparaju, K., Bhatt, K. G., Gowda, T. V. A platelet aggregation inhibitor phospholipase A'2 from Russell's viper ( Vipera russelli) venom: isolation and characterization. Toxicon, 1996, 34, 1173-1185.
301. Li, Y. S., Liu, K. F., Wang, Q. C., Ran, Y. L., Tu, G. C. A platelet function inhibitor purified from Vipera russelli siamensis (Smith) snake venom. Toxicon, 1985, 23, 895-903.
302. Li, Y. S., Liu, K. F., Wang, Q. C. Mechanism of action of the platelet function inhibitor from Vipera russelli siamensis snake venom. Toxicon, 1986, 24, 875-883.
303. 2 purified from Heloderma horridum (beaded lizard) venom. Biochim. Biophys. Acta, 1994, 1211 61-68.
304. Ouyang, C., Hwang, L. J., Huang, T. F. α-Fibrogenase from Agkistrodon rhodostoma (Malayan pit viper) snake venom. Toxicon, 1983, 21, 25-33.
305. Ouyang, C., Hwang, L. J., Huang, T. F. Inhibition of rabbit platelet aggregation by α-fibrogenase purified from Calloselasma rhodostoma (Malayan pit viper) venom. J. Formosan. Med. Assoc., 1985, 84, 1197-1206.
306. Ouyang, C., Teng, C. M., Chen, Y. C. Physicochemical properties of α- and β-fibrinogenases of Trimeresurus mucrosquamatus venom. Biochim. Biophys. Acta, 1977, 481, 622-630.
307. Gasmi, A., Karoui, M., Benlasfar, Z., Karoui, H., El Ayeb, M., Dellagi, K. Purification and characterization of a fibrinogenase from Vipera lebetina (desert adder) venom. Toxicon, 1991, 29, 827-836.
308. Gasmi, A., Guermazi, S., Chabchoub, A., Makni, K., Karoui, H., El Ayeb, M., Dellagi, K. Effect of a fibrinogenase from Vipera lebetina venom on human blood coagulation factors and platelets. Toxicon, 1993, 31, 520.
309. Kamiguti, A. S., Slupsky, J. R., Zuzel, M., Hay, C. R. Properties of fibrinogen cleaved by Jararhagin, a metalloproteinase from the venom of Bothrops jararaca. Thromb. Haemost., 1994, 72 244-249.
310. Huang, T. F., Chang, M. C., Peng, H. C., Teng, C. M. A novel α-type fibrinogenase from Agkistrodon rhodostoma snake venom. Biochim. Biophys. Acta, 1992, 1160, 262-268.
311. Fujimura, S., Rikimara, T., Baba, S., Hori, J., Hao, X. Q., Terada, S., Kimoto, E. Purification and characterization of a non-hemorrhagic metalloproteinase from Agkistrodon halys brevicaudus venom. Biochim. Biophys. Acta, 1995, 1243, 94-100.
312. Evans, H. J. Purification and properties of a fibrinogenase from the venom of Naja nigricollis. Biochim. Biophys. Acta, 1984 802, 49-54.
313. Zhou, Q., Smith, J. B., Grossman, M. H. Molecular cloning and expression of catrocollastatin, a snake-venom protein from Crotalus atrox (western diamondback rattlesnake) which inhibits platelet adhesion to collagen. Biochem. J., 1995, 307, 411-417.
314. Kamiguti, A. S., Gallagher, P., Marcinkiewicz, C., Theakston, R. D. G., Zuzel, M., Fox, J. W. Identification of sites in the cysteine-rich domain of the class P-III snake venom metalloproteinases responsible for inhibition of platelet function. FEBS Lett., 2003, 549, 129-134.
315. 2+ channel binding site of calciseptine and FS2. Biochemistry, 1998, 37, 9058-9063.